Aug 13, 2020
Regulus Therapeutics Reports Second Quarter 2020 Financial Results and Recent Updates
May 14, 2020
Regulus Therapeutics Reports First Quarter 2020 Financial Results and Recent Updates
Mar 12, 2020
Regulus Reports Fourth Quarter and Year-End 2019 Financial Results and Recent Updates
Jan 24, 2020
Non-Alcoholic Steatohepatitis (NASH) H1, 2020: Pipeline Landscape; Therapeutics Development & Assessment, Drug Profiles, Dormant Projects, Discontinued Products
Oct 16, 2019
Regulus Therapeutics Presents Preclinical Data Identifying RGLS4326 as a Potential Disease-Modifying Treatment for Autosomal Dominant Polycystic Kidney Disease at OTS Annual Meeting
Sep 12, 2019
Regulus Therapeutics Announces Publication in Nature Communications Identifying RGLS4326 as a Potential Promising Treatment for ADPKD
Sep 03, 2019
Regulus Therapeutics to Present at the H.C. Wainwright Global Investment Conference
Aug 08, 2019
Regulus Therapeutics Reports Second Quarter 2019 Financial Results and Recent Updates
Jul 23, 2019
Regulus Therapeutics Announces RGLS4326 Program Update
Jun 11, 2019
Regulus Announces New Additions to Board of Directors
May 09, 2019
Regulus Therapeutics Reports First Quarter 2019 Financial Results and Recent Updates
May 06, 2019
Regulus Therapeutics Announces Restructuring of Term Loan
Mar 15, 2019
Regulus Announces Transition of Research Leadership
Nov 19, 2018
Regulus Presents Preclinical Survival Data Highlighting Potential of Novel Treatment for Glioblastoma Multiforme
Nov 08, 2018
Regulus Reports Third Quarter 2018 Financial Results and Recent Updates
Nov 06, 2018
Regulus Announces Successful Restructuring of Sanofi Collaboration
Oct 25, 2018
Regulus to Present Data from ATHENA, a Global Natural History of Disease Study for Alport Syndrome, at ASN's Kidney Week 2018
Oct 22, 2018
Regulus to Present Preclinical Data Supporting RGLS4326 as a Novel Therapeutic in Development for Autosomal Dominant Polycystic Kidney Disease at ASN's Kidney Week 2018
Oct 18, 2018
Regulus Regains Compliance with NASDAQ Listing Requirements
Oct 02, 2018
Regulus to Participate in Fireside Chat at the Chardan Genetic Medicines Conference